VMA mass screening program of neuroblastoma for infants in Nagoya City, Japan. | Zendy

Kuniaki KODAMA | Zendy; Takao Nakata | Zendy; Junnosuke Ishii | Zendy; Kinuko Mitani | Zendy; Hidehiko Tsunooka | Zendy; Akira Masaoka | Zendy; Mitsuko Aoyama | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

VMA mass screening program of neuroblastoma for infants in Nagoya City, Japan.

Author(s) -

Kuniaki KODAMA,

Takao Nakata,

Junnosuke Ishii,

Kinuko Mitani,

Hidehiko Tsunooka,

Akira Masaoka,

Mitsuko Aoyama

Publication year - 1985

Publication title -

american journal of public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.284

H-Index - 264

eISSN - 1541-0048

pISSN - 0090-0036

DOI - 10.2105/ajph.75.2.173

Subject(s) - neuroblastoma , medicine , asymptomatic , urine , pediatrics , environmental health , surgery , genetics , biology , cell culture

In Nagoya City, Japan, VMA mass screening for detection of neuroblastoma has been performed since 1977. Filter paper strips wetted with urine are mailed to a central laboratory. Positive tests are followed up by more definitive testing. Of the 20,053 urine samples of 6-month-old infants tested, January 1977 to March 1983, five asymptomatic infants with neuroblastoma have been discovered. All have been treated and are alive as of January 1984.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research